ABDIIBRAHIM - Trademark Details
Status: 686 - Published For Opposition
Serial Number
90064573
Word Mark
ABDIIBRAHIM
Status
686 - Published For Opposition
Status Date
2021-12-21
Filing Date
2020-07-21
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
210312, 260118, 260121 - Targets without crosshairs or alignment guides. Three or more concentric circles. Circles that are totally or partially shaded.
Published for Opposition Date
2021-12-21
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
FLETCHER, TRACY L
Statements
Indication of Colors claimed
The color(s) blue, gray and white is/are claimed as a feature of the mark.
Description of Mark
The mark consists of three concentric circles divided in half where the center circle is blue on the left side and white on the right side, the next circle is white on the left side and blue on the right side and the outer circle is blue on the left side and white on the right side and is outlined in blue on the outer right side. The circle design appears to the left of the wording "ABDIIBRAHIM" in gray stylized font. The remaining white represents background and does not form part of the mark.
Goods and Services
Pharmaceutical preparations used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, muscular, dermatological, pulmonary, respiratory, oncological, hepatological, viral, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, ophthalmic, neurological, hormonal, and psychiatric diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceutical preparations to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements and preparations; antiallergic medicines, antidiarrheal medicines, medicines for intestinal disorders, motion sickness medicines, medicines for the treatment of gastrointestinal diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal herbal preparations; medicinal preparations for the treatment of diseases of the mouth in the form of sprays; medicinal creams for skin care; propolis for medicinal or therapeutic purposes; medicinal preparations for the treatment of infectious diseases and for use in oncology; medicinal preparations for the treatment of diseases of the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; medicinal syrups for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; vitamin and mineral supplements; medicinal syrups containing sodium saccarine, glycerine, banana aroma, strawberry aroma, fruit aroma, orange flavour, sucralose, nicotimanid, fish oil, pelargonium sidoides, xanthan gum, bubble gum aroma, red food dye, peach aroma, yellow food dye, raspberry extract, indigo blue food dye, and caramel for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical skin lotions; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for treating hypertension; pharmaceutical antitussive-cold preparations; pharmaceutical preparations for skin wounds; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating asthma; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for treating diseases and disorders of the central nervous system; pharmaceutical preparations for treating allergic rhinitis and asthma; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; all of the foregoing being medicines for human health
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-08-18
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jefferson F. Scher
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
Turkey | False | ||
False | |||
False |
Trademark Events
Event Date | Event Description |
2020-07-24 | NEW APPLICATION ENTERED IN TRAM |
2020-08-18 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-08-19 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-11-04 | ASSIGNED TO EXAMINER |
2020-11-04 | NON-FINAL ACTION WRITTEN |
2020-11-04 | NON-FINAL ACTION E-MAILED |
2020-11-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-05-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-05-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-05-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-05-10 | FINAL REFUSAL WRITTEN |
2021-05-10 | FINAL REFUSAL E-MAILED |
2021-05-10 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-11-09 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2021-11-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-11-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-11-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-11-12 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2021-11-16 | ELECTRONIC RECORD REVIEW COMPLETE |
2021-12-01 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-12-21 | PUBLISHED FOR OPPOSITION |
2021-12-21 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |